LSL logo

LSL Pharma Group Inc. Stock Price

TSXV:LSL Community·CA$42.4m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

LSL Share Price Performance

CA$0
-0.45 (-100.00%)
CA$0
-0.45 (-100.00%)
Price CA$0

LSL Community Narratives

There are no narratives available yet.

Snowflake Analysis

Low risk and slightly overvalued.

3 Risks
2 Rewards

LSL Pharma Group Inc. Key Details

CA$23.2m

Revenue

CA$16.4m

Cost of Revenue

CA$6.8m

Gross Profit

CA$3.3m

Other Expenses

CA$3.6m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
0.029
29.41%
15.36%
96.1%
View Full Analysis

About LSL

Founded
n/a
Employees
185
CEO
Francois Roberge
WebsiteView website
www.groupelslpharma.com

LSL Pharma Group Inc. develops, manufactures, and commercializes sterile pharmaceutical products, cosmetic products, and natural health products in Canada, the United States, and internationally. The company offers dietary supplements and vitamins in the tablet and capsule form; niche sterile ophthalmic products in the form of ointments and drops; and cosmetic, pharmaceutical, and natural health products in liquid and semi-solid form for pharmacy banners and hospitals. The company is headquartered in Boucherville, Canada.

Recent LSL News & Updates

LSL Pharma Group's (CVE:LSL) Solid Profits Have Weak Fundamentals

Sep 02
LSL Pharma Group's (CVE:LSL) Solid Profits Have Weak Fundamentals

Recent updates

No updates